John A Orwin

John Orwin is the President and CEO of Atreca. He was the President and CEO at Relypsa before that. Prior to Relypsa, Mr. Orwin served as chief executive officer and a member of Affymax’s board of directors starting in February 2011. From April 2010 to January 2011, he served as president and chief operating officer of Affymax. From 2005 to 2010, Mr. Orwin served as vice president and then senior vice president, BioOncology Business Unit, at Genentech, where he was responsible for all marketing, sales, business unit operations, and pipeline brand management for Genentech's oncology portfolio in the United States. From 2001 to 2005, Mr. Orwin served in various executive-level positions at Johnson & Johnson, overseeing oncology therapeutic commercial and portfolio expansion efforts in the US. He has also held senior marketing and sales positions at Alza Pharmaceuticals, Sangstat Medical Corporation, Rhone-Poulenc Rorer Pharmaceuticals, and Schering-Plough Corporation. Mr. Orwin holds an M.B.A. from New York University and a B.A. from Rutgers University.

John A Orwin is the President and CEO at Atreca, based in United States, North America. With a background in Biotechnology, John A Orwin has a rich history of leadership and innovation.John A Orwin studied M.B.A International Business at NYU Stern School of Business. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.